<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lui VG</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NIDDK NIH HHS</funding><funding>Immunology Training Program</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>Jeffrey Modell Foundation</funding><funding>Kennedy Trust</funding><funding>NIAMS NIH HHS</funding><funding>Wellcome Trust</funding><funding>Cancer Research Institute</funding><funding>National Science Foundation</funding><pagination>e20230927</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10644909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>221(1)</volume><pubmed_abstract>Lymphocyte-specific protein tyrosine kinase (LCK) is essential for T cell antigen receptor (TCR)-mediated signal transduction. Here, we report two siblings homozygous for a novel LCK variant (c.1318C>T; P440S) characterized by T cell lymphopenia with skewed memory phenotype, infant-onset recurrent infections, failure to thrive, and protracted diarrhea. The patients' T cells show residual TCR signal transduction and proliferation following anti-CD3/CD28 and phytohemagglutinin (PHA) stimulation. We demonstrate in mouse models that complete (Lck-/-) versus partial (LckP440S/P440S) loss-of-function LCK causes disease with differing phenotypes. While both Lck-/- and LckP440S/P440S mice exhibit arrested thymic T cell development and profound T cell lymphopenia, only LckP440S/P440S mice show resi</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.</pubmed_title><pmcid>PMC10644909</pmcid><funding_grant_id>P30 CA046934</funding_grant_id><funding_grant_id>P30 DK116073</funding_grant_id><funding_grant_id>CRI4503</funding_grant_id><funding_grant_id>100262Z/12/Z</funding_grant_id><funding_grant_id>K23 AR070897</funding_grant_id><funding_grant_id>K23AR070897</funding_grant_id><funding_grant_id>KENN202117</funding_grant_id><funding_grant_id>DGE-1938058</funding_grant_id><funding_grant_id>224343/Z/21/Z</funding_grant_id><funding_grant_id>T32 AI07405</funding_grant_id><funding_grant_id>T32 AI007405</funding_grant_id><funding_grant_id>KENN202114</funding_grant_id><pubmed_authors>Acharya A</pubmed_authors><pubmed_authors>Jacobsen EM</pubmed_authors><pubmed_authors>Capera J</pubmed_authors><pubmed_authors>Minguet S</pubmed_authors><pubmed_authors>Lundquist K</pubmed_authors><pubmed_authors>Dustin ML</pubmed_authors><pubmed_authors>Baxter RM</pubmed_authors><pubmed_authors>Cambier JC</pubmed_authors><pubmed_authors>Gumbart JC</pubmed_authors><pubmed_authors>Pannicke U</pubmed_authors><pubmed_authors>Hoenig M</pubmed_authors><pubmed_authors>Schwarz K</pubmed_authors><pubmed_authors>Lui VG</pubmed_authors><pubmed_authors>Cabrera-Martinez B</pubmed_authors><pubmed_authors>Hartl FA</pubmed_authors><pubmed_authors>Garcia-Perez JE</pubmed_authors><pubmed_authors>Matusewicz P</pubmed_authors><pubmed_authors>Niewolik D</pubmed_authors><pubmed_authors>Schamel WW</pubmed_authors><pubmed_authors>D'Abramo M</pubmed_authors><pubmed_authors>Debatin KM</pubmed_authors><pubmed_authors>Lorenz M</pubmed_authors><pubmed_authors>Schulz AS</pubmed_authors><pubmed_authors>Bailey O</pubmed_authors><pubmed_authors>Alba J</pubmed_authors><pubmed_authors>Hsieh EWY</pubmed_authors></additional><is_claimable>false</is_claimable><name>A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.</name><description>Lymphocyte-specific protein tyrosine kinase (LCK) is essential for T cell antigen receptor (TCR)-mediated signal transduction. Here, we report two siblings homozygous for a novel LCK variant (c.1318C>T; P440S) characterized by T cell lymphopenia with skewed memory phenotype, infant-onset recurrent infections, failure to thrive, and protracted diarrhea. The patients' T cells show residual TCR signal transduction and proliferation following anti-CD3/CD28 and phytohemagglutinin (PHA) stimulation. We demonstrate in mouse models that complete (Lck-/-) versus partial (LckP440S/P440S) loss-of-function LCK causes disease with differing phenotypes. While both Lck-/- and LckP440S/P440S mice exhibit arrested thymic T cell development and profound T cell lymphopenia, only LckP440S/P440S mice show resi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-07-14T18:38:30.722Z</modification><creation>2024-11-09T11:16:28.796Z</creation></dates><accession>S-EPMC10644909</accession><cross_references><pubmed>37962568</pubmed><doi>10.1084/jem.20230927</doi></cross_references></HashMap>